Author Question: One explanation for the differences between the Genain sisters in their experience of schizophrenia ... (Read 14 times)

leilurhhh

  • Hero Member
  • *****
  • Posts: 560
One explanation for the differences between the Genain sisters in their experience of schizophrenia is
 
  a. The deterioration of the uteral envionrment
 b. De novo mutations in the fertilized egg or germ cells
  c. Birth order
 d. Being raised in different households

Question 2

Psychosocial clubs or clubhouses for patients with schizophrenia have been formed as a part of some rehabilitation programs. Research indicates that participation in these clubs may help prevent relapses. However, it is difficult to interpret the improvement in these patients because
 
  a. some patients are on medication and some aren't.
 b. only the most psychotic patients participate.
 c. patients who participate may be significantly different from those who don't.
  d. a significant number of patients drop out before completing the program.



lauravaras

  • Sr. Member
  • ****
  • Posts: 347
Answer to Question 1

b

Answer to Question 2

c



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Allergies play a major part in the health of children. The most prevalent childhood allergies are milk, egg, soy, wheat, peanuts, tree nuts, and seafood.

Did you know?

Prostaglandins were first isolated from human semen in Sweden in the 1930s. They were so named because the researcher thought that they came from the prostate gland. In fact, prostaglandins exist and are synthesized in almost every cell of the body.

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

After a vasectomy, it takes about 12 ejaculations to clear out sperm that were already beyond the blocked area.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library